• share
• favorite_border

New evidence-based clinical practice guidelines for the prevention, diagnosis, and treatment of Lyme disease have been developed by a multidisciplinary panel led by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology. Representatives from an additional 12 medical specialties and patients also served on the panel.

• share
• favorite_border

• share
• favorite_border

The Families First Coronavirus Response Act (H.R. 6201) represents swift action by the House of Representatives to bolster federal responses to the spread of coronavirus and aims to reduce the pandemic’s impacts on Americans’ safety and financial security, while addressing an ongoing COVID-19 testing backlog.

• share
• favorite_border

• share
• favorite_border

Earlier today, a release was issued stating that antibiotic maker Melinta is closing. This information was incorrect. Melinta has filed for Chapter 11 bankruptcy but intends to remain open and is in the process of restructuring. The bankruptcy filing announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.

• share
• favorite_border

Today’s subcommittee hearing on U.S. preparedness and responses for the 2019-2020 flu season offers an important opportunity to examine and act on gaps and challenges exacerbating the public health threats of seasonal influenza outbreaks.

• share
• favorite_border

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health. As physicians and scientists on the front lines of a growing public health crisis, the Infectious Diseases Society of America urges federal policy makers to respond to the report’s warning with investments and commitment to turning the tide of antibiotic resistance.

• share
• favorite_border

When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room (ER), they require timely, expert care to prevent organ failure and even death. When that care includes the early involvement of an infectious disease (ID) specialist, patient mortality can be reduced by as much as 40 percent, according to a new retrospective, single-center study published in Open Forum Infectious Diseases.

• share
• favorite_border

A device designed to improve adherence to outpatient parenteral antimicrobial therapy (OPAT) took top prize at the second IDEA Incubator, a competition showcasing inventions, products and devices to improve patient care for infectious diseases, which takes place during IDWeek.

• share
• favorite_border

The Centers for Medicare and Medicaid Services’ new rule requiring hospitals participating in its programs to establish antibiotic stewardship programs will enable critical advances toward control of a major public health threat.

• share
• favorite_border

As government, business, and community leaders from around the world gather in New York today for the United Nations Secretary-General’s Climate Action Summit, attention to the immediate and international threats posed by climate change to human health will be critical to achieving the summit’s goals of advancing from words to urgent action.

• share
• favorite_border

Spending bills released by Senate Appropriations Committee Wednesday demonstrate encouraging recognition of some of the most urgent health challenges threatening individual and public health at home and abroad. At the same time, the bills fall short of the comprehensive commitments necessary to fully effective responses.

• share
• favorite_border

A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA). Published as a supplement to The Journal of Infectious Diseases (JID), the IDSA-sponsored collection includes articles written by both Society members and authors outside the field with deep knowledge and seasoned perspectives on these important issues.

• share
• favorite_border

A CDC report on antibiotics use in health care U.S. healthcare settings show progress made in promoting appropriate use of infection-fighting drugs, but strengthened and continued efforts needed.

• share
• favorite_border

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have extended the public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease for an additional 30 days. The deadline to submit comments is now Sept. 9, 2019.

• share
• favorite_border

The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines. At the same time, the rule does not require or support antibiotic stewardship in healthcare settings, also an essential measure to protect the effectiveness of existing infection-fighting medicines.

• share
• favorite_border

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have opened a public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease.

• share
• favorite_border

The reauthorization of the Pandemic and All-Hazards Preparedness Act signed by the president Monday includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.

• share
• favorite_border

The introduction of the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms -- DISARM -- Act -- by United States Senators Johnny Isakson (R-GA) and Bob Casey (D-PA) Tuesday represents an essential step toward addressing the growing threat of infections that are increasingly resistant to existing treatments. By improving critical Medicare reimbursement for antibiotics and promoting their appropriate use, the legislation has the potential to stabilize the antibiotics market, spur the development of new infection-fighting drugs, and preserve the effectiveness of existing medicines.

• share
• favorite_border

Drug Company Closing Underscores Needs for Swift Federal Action Supporting Antibiotic Development, Stewardship

• share
• favorite_border

The Infectious Diseases Society of America Dispels Dangerous Measles Vaccine Myths

• share
• favorite_border

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

• share
• favorite_border

With evidence that the number of measles cases and outbreaks this year is already well on track to exceed last year’s numbers, today’s Senate Committee on Health, Education, Labor and Pensions hearing is drawing urgent attention to a central tenet of public health: vaccines save lives.

• share
• favorite_border

A District Court injunction preventing the military discharge of two Air Force members living with HIV was responsive to medical evidence and reflected important recognition of advances in treatment for HIV, as well as of the abilities of people with the virus to enjoy productive healthy lives.

• share
• favorite_border

People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in the Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines. The large prospective study expands on previous research by examining the risk of shingles before and after a new cancer diagnosis and across a range of cancer types among approximately 240,000 adults in Australia from 2006 to 2015.

• share
• favorite_border

The latest developments in the diagnosis and treatment of infectious diseases are being presented in New Orleans, Sept. 7-10, at the 38th Annual Scientific Meeting of the Infectious Diseases Society of America.